摘要
The present disclosure is directed to a regulator, a pharmaceutical composition encompassing the regulator and the application thereof The regulator modulates the expression integrins and/or EMP2, and is employed for treating integrins-associated and/or EMP2-associated diseases
| 貢獻的翻譯標題 | 調控物及含有該調控物的醫藥組合物 |
|---|---|
| 原文 | English |
| 專利號 | ZL 2013 1 0177660.2 |
| 出版狀態 | Published - 1800 |